Model, despite the fact that IL-2 in mixture with SBRT-induced anti-tumor responses in
Model, despite the fact that IL-2 in combination with SBRT-induced anti-tumor responses in human melanoma sufferers . Our data consequently suggest that SBRT combined with -CD137/-PD-1 mAbs might be superior…